Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
By L. S. Munoz-Price, L. Poirel, Robert A. Bonomo, M. Schwaber, G. Daikos, M. Cormican, G. Cornaglia, J. Garau, M. Gniadkowski, M. Hayden and 11 more. Lancet. Infectious Diseases (Print), 2013
1,554 citations recorded by the source corpus.
Klebsiella pneumoniae carbapenemases (KPCs) were originally identified in the USA in 1996. Since then, these versatile β-lactamases have spread internationally among Gram-negative bacteria, especially K pneumoniae, although their precise epidemiology is diverse across countries and regions. The mortality described among patients infected with organisms positive for KPC is high, perhaps as a result of the limited antibiotic options remaining (often colistin, tigecycline, or aminoglycosides). Triple drug combinations using colistin, tigecycline, and imipenem have recently been associated with improved survival among patients with bacteraemia. In this Review, we summarise the epidemiology of KPCs across continents, and discuss issues around detection, present antibiotic options and those in development, treatment outcome and mortality, and infection control. In view of the limitations of present treatments and the paucity of new drugs in the pipeline, infection control must be our primary defence for now.
Subfields: Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/62c5796f0e4dc170bbcac90bc446a51eb9f5e59b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In Molecular Medicine
In Pharmacology
Citations in the corpus
- The global epidemiology of carbapenemase-producing Enterobacteriaceae (2017, background): “This initial report was followed by a large number of cases of KPC-producing CPE reported from New York City area hospitals.(14) In a New York-based multicenter survey, the prevalence of blaKPC within K.”
- The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. (2014, background): “The IMI enzymes (IMIpenemhydrolyzing ß-lactamase) have been detected in rare isolates of Enterobacter spp. in USA [7], France [8], Croatia [9], Finland [10] and Argentina[11], and more recently a colistin-resistant ht tp :// do c. re ro .c h p Enterobacter asburiae isolate was recovered in Ireland [”
- Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance (2015, background): “To date, blaKPC has been found in more than 100 different STs, but this pandemic is driven primarily by the spread of KPCproducing K. pneumoniae isolates that are members of clonal complex 258 (CC258) (18).”
- Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance (2017, background): “These super strains may be practically resistant to all available classes of antibiotics, posing a great challenge to clinicians due to limited available treatment options (Munoz-Price et al. 2013; Nordmann and Poirel 2014), and are highlighted further in this review.”
- The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace (2017, background): “pneumoniae that are endemic in an increasing number of countries and are responsible for many major outbreaks worldwide [8, 34].”
- Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread (2019, background): “Emergence of carbapenem resistance seems to occur in clinical [8], urban (9) and agricultural settings (10) and is a worldwide phenomenon [11–13].”
- Carbapenem Resistance: A Review (2017, background): “A number of KPC genetic lineages were identified in Colombia; namely Pseudomonas aeruginosa ST235, ST308, ST1006 and ST1060, while in Klebsiella pneumoniae, ST258 and ST51233 were identified [73,182].”
- The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae (2015, background): “To date, blaKPC has been found in 100 different STs, but this pandemic is driven primarily by the spread of KPC-producing K. pneumoniae isolates that are members of clonal complex 258 (CC258) (121).”
- Identification of antimicrobial peptides from the human gut microbiome using deep learning (2022, background): “Data are presented as mean values ± s.e.m. 58,59 .”